Target intelligence / Profile preview

Homeodomain-interacting protein kinase 3 mRNA 3′ untranslated region (HIPK3 mRNA 3′UTR) (HIPK3 mRNA 3′UTR)

Target
HIPK3 mRNA 3′UTR
Molecular classification
Untranslated region, Messenger RNA, Regulatory RNA element
01

Overview

The Homeodomain-interacting protein kinase 3 (HIPK3) mRNA 3′ untranslated region (3′UTR) is a critical regulatory segment of the HIPK3 transcript that governs the stability and translation of the HIPK3 protein (UniProt Q9H422). HIPK3 is a serine/threonine kinase involved in diverse cellular processes, including apoptosis, glucose metabolism, and the cell cycle. The 3′UTR serves as a primary docking site for various microRNAs (miRNAs), such as miR-193a-3p and miR-338-3p, which post-transcriptionally repress HIPK3 expression (PubMed: 25823897, 21880712). Dysregulation of this regulatory axis is implicated in several pathologies; for instance, reduced miRNA binding or 3′UTR mutations can lead to HIPK3 overexpression, promoting oncogenesis and chemoresistance in various cancers (PubMed: 25823897). In metabolic contexts, the HIPK3 3′UTR-miRNA interaction is essential for maintaining pancreatic beta-cell function and insulin secretion (PubMed: 21880712). Furthermore, the HIPK3 gene also produces a circular RNA (circHIPK3) that acts as a sponge for these same miRNAs, thereby indirectly protecting the mRNA 3′UTR from repression (PubMed: 30033884). Consequently, the HIPK3 mRNA 3′UTR is an emerging focal point for RNA-targeted therapeutic strategies, including the use of antisense oligonucleotides (ASOs) and miRNA mimics designed to modulate HIPK3 levels for treating cancer and metabolic disorders.

Other names
HIPK3 3'UTRDYRK6 mRNA 3'UTRFIST3 mRNA 3'UTRPKY mRNA 3'UTRHomeodomain-interacting protein kinase 3 3-prime untranslated region
02

Mechanism of action

Binding of microRNA mimics or antisense oligonucleotides to the 3′UTR to induce mRNA degradation or prevent translation of the HIPK3 protein.

03

Biological functions

Post-transcriptional regulationmRNA stability controlTranslation regulationMicroRNA binding
04

Disease associations

CancerDiabetes mellitusCardiovascular diseaseOsteoarthritis
05

Safety considerations

Off-target hybridization of RNA-based therapeuticsInnate immune activation by synthetic oligonucleotidesDelivery-related toxicity of lipid nanoparticles or viral vectors
06

Interacting drugs

miR-193a-3p mimics (experimental)

2 more in the full profile.

07

Biomarkers

HIPK3 mRNA expression levelsmiR-193a-3p expression levelsmiR-338-3p expression levels

Beyond the preview

Go deeper on Homeodomain-interacting protein kinase 3 mRNA 3′ untranslated region (HIPK3 mRNA 3′UTR) (HIPK3 mRNA 3′UTR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Homeodomain-interacting protein kinase 3 mRNA 3′ untranslated region (HIPK3 mRNA 3′UTR) (HIPK3 mRNA 3′UTR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call